Loading
A phase 2 trial of QL1706 and cAPOX (capecitabine, oxaliplatin) in colorectal cancer, run by Qilu Hospital of Shandong University, not yet recruiting.
QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer is a phase 2, interventional study registered as NCT07156682 by Qilu Hospital of Shandong University, with a registry enrolment figure of 21 participants, started 2025-09-25 and due to reach its primary completion in 2027-06-30. Interventions recorded: QL1706; XELOX. Conditions listed: Colon Cancer; MSS/pMMR; QL1706. Primary outcome: Pathological Complete Response (pCR). Colorectal eligibility wording from the registry: "* Histologically or clinically confirmed initially resectable Stage III colon cancer according to the AJCC 8th edition". Sites: China. No results are recorded here; the registry entry is the source.
Shares QL1706, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares QL1706, Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag colorectal-deep-dive.
Shares QL1706, Platinum agents, Colorectal cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag colorectal-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.